BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1017 related articles for article (PubMed ID: 28218562)

  • 1. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoprotein 1 (osteopontin) gene (rs4754) affects markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus.
    Pleskovič A; Šantl Letonja M; Cokan Vujkovac A; Makuc J; Nikolajević Starčević J; Petrovič D
    Int Angiol; 2018 Feb; 37(1):64-70. PubMed ID: 28990744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms XbaI (rs693) and EcoRI (rs1042031) of the ApoB gene are associated with carotid plaques but not with carotid intima-media thickness in patients with diabetes mellitus type 2.
    Nikolajevic Starcevic J; Santl Letonja M; Praznikar ZJ; Makuc J; Vujkovac AC; Petrovic D
    Vasa; 2014 May; 43(3):171-80. PubMed ID: 24797048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX6 gene polymorphism (rs16933090) and markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus.
    Pleskovič A; Šantl Letonja M; Cokan Vujkovac A; Kruzliak P; Petrovič D
    Int Angiol; 2016 Dec; 35(6):552-556. PubMed ID: 26868133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study.
    Eltoft A; Arntzen KA; Hansen JB; Wilsgaard T; Mathiesen EB; Johnsen SH
    Atherosclerosis; 2017 Aug; 263():293-300. PubMed ID: 28728065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between high sensitivity C-Reactive protein and prevalence of asymptomatic carotid artery stenosis.
    Huang X; Wang A; Liu X; Chen S; Zhu Y; Liu Y; Huang K; Wu J; Chen S; Wu S; Zhao X
    Atherosclerosis; 2016 Mar; 246():44-9. PubMed ID: 26752692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Starčević JN; Caprnda M; Curilla E; Mozos I; Kruzliak P; Prosecky R; Petrovič D
    Vasa; 2017 Aug; 46(5):363-369. PubMed ID: 28521653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Association Between High-Sensitivity C-Reactive Protein and Carotid Intima-Media Progression: The APAC Study.
    Wang A; Huang X; Liu X; Su Z; Wu J; Chen S; Liu X; Ruan C; Guo X; Wu S; Zhao X
    J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):252-259. PubMed ID: 27742537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
    Cardoso CRL; Salles GC; Leite NC; Salles GF
    Cardiovasc Diabetol; 2019 Jan; 18(1):2. PubMed ID: 30630491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Hs-CRP/adiponectin ratio is associated with increase carotid intima-media thickness.
    Liao H; Li Z; Zheng D; Liu J; Liu Y; Xiao C; Wang H
    Lipids Health Dis; 2014 Jul; 13():120. PubMed ID: 25070472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players.
    Virani SS; Pompeii L; Lincoln AE; Dunn RE; Tucker AM; Nambi V; Nasir K; Vogel RA; Boone JL; Roberts AJ; Ballantyne CM
    Atherosclerosis; 2012 Jun; 222(2):551-6. PubMed ID: 22525822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis.
    Hashimoto H; Kitagawa K; Hougaku H; Shimizu Y; Sakaguchi M; Nagai Y; Iyama S; Yamanishi H; Matsumoto M; Hori M
    Circulation; 2001 Jul; 104(1):63-7. PubMed ID: 11435339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive study of the relationship between the subclinical carotid disease and biomarkers, carotid femoral pulse wave velocity in patients with hypertension.
    Zhao X; Bo L; Zhao H; Li L; Zhou Y; Wang H
    Clin Exp Hypertens; 2018; 40(3):274-280. PubMed ID: 29227169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between high-sensitivity C-reactive protein and subclinical carotid atherosclerosis stratified by glucose metabolic status in Chinese adults.
    Su H; Pei Y; Tian C; Zhang Q; Liu L; Meng G; Yao Z; Wu H; Xia Y; Bao X; Gu Y; Sun S; Wang X; Zhou M; Jia Q; Song K; Sun Z; Niu K
    Clin Cardiol; 2019 Jan; 42(1):39-46. PubMed ID: 30318598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis.
    Amor AJ; Catalan M; Pérez A; Herreras Z; Pinyol M; Sala-Vila A; Cofán M; Gilabert R; Ros E; Ortega E
    Atherosclerosis; 2016 Apr; 247():161-9. PubMed ID: 26921744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis associated with dynamic inflammation changes after multifactorial intervention in short-duration type 2 diabetes: A randomized, controlled, 10-year follow-up trial.
    Shi C; Men L; Yu C; Yao J; Bai R; Yang Y; Sun L; Sun G; Song G; Zhang Y; Xing Q; Du J
    J Diabetes Complications; 2017 Aug; 31(8):1286-1292. PubMed ID: 28610945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of C-reactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus.
    Mita T; Watada H; Uchino H; Shimizu T; Hirose T; Tanaka Y; Kawamori R
    Endocr J; 2006 Oct; 53(5):693-8. PubMed ID: 16926521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Tsanikidis H; Vitta I; Karkos C; Karayannacos PE; Gerasimidis T; Liapis CD
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):75-80. PubMed ID: 19834878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of manganese superoxide dismutase and glutathione S-transferases genotypes with carotid atherosclerosis in patients with diabetes mellitus type 2.
    Santl Letonja M; Letonja M; Ikolajević-Starcević JN; Petrovic D
    Int Angiol; 2012 Feb; 31(1):33-41. PubMed ID: 22330623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.